NCT03801460

Brief Summary

The PREPARE TAVR pilot study will examine the effects of remotely administered physiological reconditioning program (RAPR) on quality of life (QOL) and clinical outcomes at one year post TAVR in frail older adults.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 9, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 11, 2019

Completed
1.5 years until next milestone

Study Start

First participant enrolled

July 1, 2020

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
Last Updated

January 13, 2021

Status Verified

January 1, 2021

Enrollment Period

1.5 years

First QC Date

January 9, 2019

Last Update Submit

January 11, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quality of Life (QOL)

    Quality of life as assessed by the Kansas City Cardiomyopathy Questionnaire (KCCQ). KCCQE is a 23-item self-administered questionnaire developed to independently measure the patient's perception of their health status, which includes heart failure symptoms, impact on physical and social function, and how their heart failure impacts their quality of life (QOL) within a 2-week recall period. KCCQ responses are provided along a rating scale continuum with equal spacing from worst to best.

    One year

Secondary Outcomes (2)

  • LOS

    Index hospitalization

  • MACE

    one year

Study Arms (2)

SOC

NO INTERVENTION

Standard of Care

RAPR

EXPERIMENTAL

Remotely administered physiological reconditioning program

Other: Remotely administered physiological reconditioning program

Interventions

Patients assigned to intervention arm will be provided a personalized, tailored and graduated exercise program to improve physical strength and conditioning.

RAPR

Eligibility Criteria

Age60 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Short Physical Performance Battery Protocol (SPPB) score \< 9

You may not qualify if:

  • Severe liver disease defined by Childs Pugh class \>B or MELD score \>15.
  • Severe kidney disease defined by eGFR \<30 mL/min.
  • Hospital admission during the 4 weeks prior to randomization.
  • Montreal objective cognitive assessment (MOCA) score \<18.
  • Mechanical fall in the past month.
  • Unstable angina during the previous month.
  • Myocardial infarction during the previous month.
  • Unsuccessful completion of the one-week run-in phase.
  • Syncopal episode during exercise during run-in phase

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Southlake Hospital

Newmarket, Ontario, Canada

RECRUITING

Related Publications (1)

  • Abraham LN, Sibilitz KL, Berg SK, Tang LH, Risom SS, Lindschou J, Taylor RS, Borregaard B, Zwisler AD. Exercise-based cardiac rehabilitation for adults after heart valve surgery. Cochrane Database Syst Rev. 2021 May 7;5(5):CD010876. doi: 10.1002/14651858.CD010876.pub3.

MeSH Terms

Conditions

Frailty

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Asim Cheema, MD

    Unity Health Toronto

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcomes assessed in a blinded manner
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, multicenter, randomized trial with objective end points assessment
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2019

First Posted

January 11, 2019

Study Start

July 1, 2020

Primary Completion

December 31, 2021

Study Completion

March 31, 2022

Last Updated

January 13, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations